Global Endoscopic Bariatric Therapy Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Endoscopic Bariatric Therapy Devices market size was valued at US$ 155 million in 2024 and is forecast to a readjusted size of USD 265 million by 2031 with a CAGR of 8.7% during review period.
Among the various developed Endoscopic Bariatric Therapy (EBT) devices, the intragastric balloon (IGB) is the most widely used in clinical settings. The IGB is inserted into the stomach via endoscopy, occupying space to reduce gastric volume and delay gastric emptying. This helps patients control appetite, reduce food intake, and facilitate weight loss. It is primarily indicated for individuals with a Body Mass Index (BMI) between 30 and 40 who have not achieved weight loss through diet and exercise, and it is also used as a bridge therapy before bariatric surgery. The IGB is reversible and typically removed endoscopically after six months. In recent years, advancements in technology have led to the development of next-generation EBT devices, such as adjustable balloons, biodegradable balloons, and endoscopic suturing techniques, providing safer, minimally invasive, and more personalized treatment options for obese patients.
This report is a detailed and comprehensive analysis for global Endoscopic Bariatric Therapy Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Key Features:
Global Endoscopic Bariatric Therapy Devices market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Endoscopic Bariatric Therapy Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Endoscopic Bariatric Therapy Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Endoscopic Bariatric Therapy Devices market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Endoscopic Bariatric Therapy Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Endoscopic Bariatric Therapy Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific (Apollo Endosurgery）, ReShape Lifesciences, Allurion, Helioscopie, Endalis, MEDSIL, Spatz Medical, Lexel, Districlass Medical, Silimed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Endoscopic Bariatric Therapy Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Intragastric Balloon
Others
Market segment by Application
Male
Female
Major players covered
Boston Scientific (Apollo Endosurgery）
ReShape Lifesciences
Allurion
Helioscopie
Endalis
MEDSIL
Spatz Medical
Lexel
Districlass Medical
Silimed
Changzhou Panda Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endoscopic Bariatric Therapy Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Endoscopic Bariatric Therapy Devices, with price, sales quantity, revenue, and global market share of Endoscopic Bariatric Therapy Devices from 2020 to 2025.
Chapter 3, the Endoscopic Bariatric Therapy Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endoscopic Bariatric Therapy Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Endoscopic Bariatric Therapy Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Endoscopic Bariatric Therapy Devices.
Chapter 14 and 15, to describe Endoscopic Bariatric Therapy Devices sales channel, distributors, customers, research findings and conclusion.
Among the various developed Endoscopic Bariatric Therapy (EBT) devices, the intragastric balloon (IGB) is the most widely used in clinical settings. The IGB is inserted into the stomach via endoscopy, occupying space to reduce gastric volume and delay gastric emptying. This helps patients control appetite, reduce food intake, and facilitate weight loss. It is primarily indicated for individuals with a Body Mass Index (BMI) between 30 and 40 who have not achieved weight loss through diet and exercise, and it is also used as a bridge therapy before bariatric surgery. The IGB is reversible and typically removed endoscopically after six months. In recent years, advancements in technology have led to the development of next-generation EBT devices, such as adjustable balloons, biodegradable balloons, and endoscopic suturing techniques, providing safer, minimally invasive, and more personalized treatment options for obese patients.
This report is a detailed and comprehensive analysis for global Endoscopic Bariatric Therapy Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Key Features:
Global Endoscopic Bariatric Therapy Devices market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Endoscopic Bariatric Therapy Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Endoscopic Bariatric Therapy Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Endoscopic Bariatric Therapy Devices market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Endoscopic Bariatric Therapy Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Endoscopic Bariatric Therapy Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific (Apollo Endosurgery）, ReShape Lifesciences, Allurion, Helioscopie, Endalis, MEDSIL, Spatz Medical, Lexel, Districlass Medical, Silimed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Endoscopic Bariatric Therapy Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Intragastric Balloon
Others
Market segment by Application
Male
Female
Major players covered
Boston Scientific (Apollo Endosurgery）
ReShape Lifesciences
Allurion
Helioscopie
Endalis
MEDSIL
Spatz Medical
Lexel
Districlass Medical
Silimed
Changzhou Panda Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endoscopic Bariatric Therapy Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Endoscopic Bariatric Therapy Devices, with price, sales quantity, revenue, and global market share of Endoscopic Bariatric Therapy Devices from 2020 to 2025.
Chapter 3, the Endoscopic Bariatric Therapy Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endoscopic Bariatric Therapy Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Endoscopic Bariatric Therapy Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Endoscopic Bariatric Therapy Devices.
Chapter 14 and 15, to describe Endoscopic Bariatric Therapy Devices sales channel, distributors, customers, research findings and conclusion.
Table of Contents
116 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Endoscopic Bariatric Therapy Devices by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
